Publication | Open Access

Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines

Medicinal ChemistryMedicineNatural SciencesRational Drug DesignMolecular BiologyNovel Cyp1b1 InhibitorsAnti-cancer AgentDrug DevelopmentPharmacologyCisplatin ResistanceCyp1b1-overexpressing LinesDrug Discovery